N.a.v. de multidisciplinaire richtlijn Diagnostiek en Behandeling van ASS bij Volwassenen is in het nascholingtijdschrift Psyfar onlangs het volgende overzichtsartikel verschenen over de medicamenteuze behandeling van ASS bij volwassenen:
Posts tonen met het label medicatie. Alle posts tonen
Posts tonen met het label medicatie. Alle posts tonen
maandag 22 juni 2015
zondag 26 oktober 2014
zaterdag 19 april 2014
Automobilisten met ADHD rijvaardiger door medicatie?
Unmedicated ADHD Patients: Accidents Waiting to Happen?
Could patients diagnosed with attention-deficit/hyperactivity disorder (ADHD) who are prescribed
ADHD medications but who drive without them be a danger to themselves and others when they drive?
ADHD medications but who drive without them be a danger to themselves and others when they drive?
New research from the Karolinska Institutet in Stockholm, Sweden, suggests that this may be the case.
According to the results of a large registry study, ADHD is associated with an increased risk for
serious transport accidents, a risk that might be reduced by ADHD medication, at least among men.
serious transport accidents, a risk that might be reduced by ADHD medication, at least among men.
"Studies have shown that ADHD is associated with serious transport accidents, but it is unclear
whether ADHD medication reduces this risk," senior author Henrik Larsson, PhD, told Medscape
Medical News. "Our study demonstrates that the risk of transport accidents with adult men with
ADHD decreases markedly if their condition is treated with ADHD medication."
whether ADHD medication reduces this risk," senior author Henrik Larsson, PhD, told Medscape
Medical News. "Our study demonstrates that the risk of transport accidents with adult men with
ADHD decreases markedly if their condition is treated with ADHD medication."
The study was published online January 29 in JAMA Psychiatry.
Medication Reduced Risk
Several other studies have shown that adults with ADHD who drive without being on medication
have less skill at the wheel compared with adults who do not have ADHD.
have less skill at the wheel compared with adults who do not have ADHD.
In a recent study presented at the 26th European College of Neuropsychopharmacology (ECNP)
Congress and reported by Medscape Medical News, Esther Sobanski, MD, from the University of
Heidelberg, in Mannheim, Germany, reported that the selective norepinephrine reuptake inhibitor
atomoxetine, approved for treating ADHD, might improve adult driving skills.
Congress and reported by Medscape Medical News, Esther Sobanski, MD, from the University of
Heidelberg, in Mannheim, Germany, reported that the selective norepinephrine reuptake inhibitor
atomoxetine, approved for treating ADHD, might improve adult driving skills.
Another study found that teenagers with ADHD became better drivers when they were trained on a
driving simulator.
driving simulator.
And in an earlier study, also reported in Medscape Medical News, researchers from the University of
Virginia in Charlottesville showed that older adults with ADHD could be more prone to automobile
accidents than their peers without the disorder.
Virginia in Charlottesville showed that older adults with ADHD could be more prone to automobile
accidents than their peers without the disorder.
 |
Dr. Henrik Larsson
|
In the current study, the investigators studied 17,408 individuals with ADHD during a period of 4
years, from 2006 to 2009, using various Swedish national registers.
years, from 2006 to 2009, using various Swedish national registers.
They then analyzed the risk for transport accidents for those diagnosed with ADHD and how use of
ADHD medication influenced this risk.
ADHD medication influenced this risk.
They found that, compared with individuals without ADHD, individuals who had ADHD had an
increased risk for serious transport accidents. For men, the adjusted hazard ratio [AHR] was 1.47;
(95% confidence interval [CI], 1.32 - 1.63), and for women, the AHR was 1.45 (95% CI, 1.24 - 1.71).
increased risk for serious transport accidents. For men, the adjusted hazard ratio [AHR] was 1.47;
(95% confidence interval [CI], 1.32 - 1.63), and for women, the AHR was 1.45 (95% CI, 1.24 - 1.71).
However, use of ADHD medication attenuated this risk.
Public Policy Implications?
In men, medication was associated with a 58% risk reduction (hazard ratio [HR], 0.42; 95% CI,
0.23 - 0.75).
0.23 - 0.75).
In women, however, there was no statistically significant association between medication use and
reduction in the risk for a transport accident.
reduction in the risk for a transport accident.
From their analyses, the researchers concluded that 41% to 49% of the accidents in male patients with
ADHD could have been avoided if they had been receiving treatment during the follow-up period of the study.
ADHD could have been avoided if they had been receiving treatment during the follow-up period of the study.
"These results may be explained by ADHD medication having an effect on the core symptoms of
ADHD, such as impulsiveness and distractibility, which in turn reduces the risk of getting trouble on
the road," Dr. Larsson said.
ADHD, such as impulsiveness and distractibility, which in turn reduces the risk of getting trouble on
the road," Dr. Larsson said.
"We could not establish a similar reduction in women's accident risk, and we need further data to be
able to comment about the effect on women with statistical certainty," he added.
able to comment about the effect on women with statistical certainty," he added.
Dr. Larsson noted that the link between ADHD and serious traffic accidents does not, by itself, justify
withholding a driver's licence. Still, he added, the findings "do suggest that a large number of injuries
and deaths due to traffic accidents associated with ADHD happened when patients were off their
medications.
withholding a driver's licence. Still, he added, the findings "do suggest that a large number of injuries
and deaths due to traffic accidents associated with ADHD happened when patients were off their
medications.
"Clinicians should consider informing their patients about the increased risk for transport accidents
and the possible benefits of ADHD medication. This would not only provide opportunities to reduce
morbidity and mortality for patients with ADHD but also contribute to the public's safety," he said.
and the possible benefits of ADHD medication. This would not only provide opportunities to reduce
morbidity and mortality for patients with ADHD but also contribute to the public's safety," he said.
Treatment Is Beneficial
Commenting on the findings for Medscape Medical News, Lenard Adler, MD, professor in the
Departments of Psychiatry and Child and Adolescent Psychiatry at New York University Langone
Medical Center, in New York City, called it "an important study because it follows up in a large,
community-based registry findings that we have shown from small treatment studies."
Departments of Psychiatry and Child and Adolescent Psychiatry at New York University Langone
Medical Center, in New York City, called it "an important study because it follows up in a large,
community-based registry findings that we have shown from small treatment studies."
 |
Dr. Lenard Adler
|
Simulator studies have shown that adults with ADHD who are untreated have impairment in driving,
and some of that impairment improves when they are treated, he said. "This study takes it out to the
real world and looks at accidents, and then shows the percent of accidents that may have been reduced
by treatment."
and some of that impairment improves when they are treated, he said. "This study takes it out to the
real world and looks at accidents, and then shows the percent of accidents that may have been reduced
by treatment."
Dr. Adler, who was not involved in this study, noted that prior research has shown that not all drivers
with ADHD have impaired driving.
with ADHD have impaired driving.
"The ADHD drivers fall into 2 groups. About half of them, from research done at Massachusetts
General, are impaired, and about half actually drive okay, but in the group that's impaired, when they
are put on a driving simulator, studies have shown that they have more speeding, false brakes, erratic
driving," said Dr. Adler.
General, are impaired, and about half actually drive okay, but in the group that's impaired, when they
are put on a driving simulator, studies have shown that they have more speeding, false brakes, erratic
driving," said Dr. Adler.
"They tend to accelerate into critical incidents on the simulator. For example, if you are driving along
and you see a tree fall on the road and accelerate into that rather than brake, it obviously has serious
consequences. If you give people with ADHD treatment, they drive better and have less of these
errors on a driving simulator," he added.
and you see a tree fall on the road and accelerate into that rather than brake, it obviously has serious
consequences. If you give people with ADHD treatment, they drive better and have less of these
errors on a driving simulator," he added.
The study by Dr. Larsson and colleagues highlights the importance of recognizing ADHD in adults,
Dr. Adler said.
Dr. Adler said.
"If you don't know you have it, you can't treat it. If individuals have poor driving records, this may
help clinicians identify some who have ADHD. This study clearly highlights the need and benefits
of treatment and the importance of adhering to ADHD treatment," he said.
help clinicians identify some who have ADHD. This study clearly highlights the need and benefits
of treatment and the importance of adhering to ADHD treatment," he said.
The study was supported by the Swedish Research Council, the Swedish Council for Working Life
and Social Research, and the National Institute of Child Health and Human Development.
Dr. Larsson reports no relevant financial relationships. Dr. Adler reports financial relationships
with Eli Lilly, Shire Pharmaceuticals, Alcobra, and Theravance.
and Social Research, and the National Institute of Child Health and Human Development.
Dr. Larsson reports no relevant financial relationships. Dr. Adler reports financial relationships
with Eli Lilly, Shire Pharmaceuticals, Alcobra, and Theravance.
JAMA Psychiatry. Published online January 29, 2014. Abstract
Send comments and news tips to news@medscape.net.
Cite this article: Unmedicated ADHD Patients: Accidents Waiting to Happen? Medscape. Jan 30, 2014.
zondag 18 november 2012
Ellende op recept
Iedere dag gaan er voor miljoenen euro’s aan medicijnen over de toonbank. Om die kosten te drukken moeten apothekers van de overheid en zorgverzekeraars hun klanten goedkopere, merkloze medicijnen aanbieden. Pillen met dezelfde werkzame stof maar met een andere vorm of kleur en in een andere verpakking. Volgens de zorgverzekeraars en de apothekers werken die pillen hetzelfde als de merkmedicijnen. Maar is dat wel zo? Epilepsie- of psychiatrische patiënten krijgen soms een ernstige terugval of raken in paniek. Het programma Zembla onderzoekt twee vragen: Wat is de invloed van de zorgverzekeraars op de apotheken? En wie is er nu verantwoordelijk voor dat patiënten het juiste middel mee naar huis krijgen?
Bekijk de documentaire van Zembla uitgezonden op 9 november 2012
zaterdag 12 mei 2012
ADHD en ASS zijn psychiatrische aandoeningen die voor de leek niet direct zichtbaar zijn, zoals bijvoorbeeld een gebroken been. Patienten met ADHD of ASS stuiten dan ook dikwijls op onbegrip t.g.v. vooroordelen en gebrek aan inzicht bij andere mensen.
Helaas is het bij politici en sommige professionals niet anders. In de politiek klinken anti-ADHD geluiden als gevolg van de gestegen ziektekosten in de GGZ en het toegenomen gebruik van ADHD medicatie. Te kort door de bocht wordt ouders verweten dat ze hun kinderen niet goed opvoeden.
Onlangs las ik in het onderstaande artikel in de Telegraaf dat psycholoog Laura Batstra, onderzoeker en docent aan de Rijksuniversiteit Groningen, de anti-ADHD hetze schaamteloos voedt:
Batstra's boektitel ’Hoe voorkom je ADHD? Door de diagnose niet te stellen’ is mijn ogen uitermate kort door de bocht en schoffeert vele psychologen en (kinder)psychiaters, die op een zorgvuldige wijze afwegen of er een ADHD diagnose gesteld kan worden. Een psychiatrische diagnose wordt in principe alleen gesteld als de symptomen ernstig genoeg zijn en gepaard gaan met disfunctioneren en lijdensdruk bij de patient en/of zijn omgeving.
Batstra's beschuldiging dat de farmacie adhd omschrijft als een hersenziekte om de verkoop van medicijnen als Ritalin, Concerta, Medikinet en Equasym op te drijven en er daarom belang bij heeft dat de diagnose ADHD wordt gesteld, stelt vele psychiaters, die deze medicatie op een weloverwogen wijze voorschrijven, onderbouwd d.m.v. wetenschappelijk onderzoek en professionele richtlijnen, in een kwaad daglicht. Ik vind de stellingname van collega Batstra te ongenuanceerd en polariserend. Met haar kanttekeningen t.a.v. de medicamenteuze behandeling van ADHD gaat ze als psycholoog in ieder geval haar boekje te buiten, omdat het buiten haar deskundigheidsgebied valt.
Hoog tijd dus voor meer nuance in het ADHD debat! In het mei-nummer van het vaktijdschrift De Psychiater vond ik het onderstaande artikel van prof. Vermeiren en Arga Paternotte, dat de benodigde nuancering aanbrengt:
Tenslotte verwijs ik naar de eerdere bijdrage in Psychotopics waarin het artikel aan bod kwam dat in 2011 verscheen in het tijdschrift Medisch Contact om stelling te nemen tegen het idee dat ADHD een modediagnose zou zijn en de bijgaande video.
Helaas is het bij politici en sommige professionals niet anders. In de politiek klinken anti-ADHD geluiden als gevolg van de gestegen ziektekosten in de GGZ en het toegenomen gebruik van ADHD medicatie. Te kort door de bocht wordt ouders verweten dat ze hun kinderen niet goed opvoeden.
Onlangs las ik in het onderstaande artikel in de Telegraaf dat psycholoog Laura Batstra, onderzoeker en docent aan de Rijksuniversiteit Groningen, de anti-ADHD hetze schaamteloos voedt:
 |
 |
Batstra's beschuldiging dat de farmacie adhd omschrijft als een hersenziekte om de verkoop van medicijnen als Ritalin, Concerta, Medikinet en Equasym op te drijven en er daarom belang bij heeft dat de diagnose ADHD wordt gesteld, stelt vele psychiaters, die deze medicatie op een weloverwogen wijze voorschrijven, onderbouwd d.m.v. wetenschappelijk onderzoek en professionele richtlijnen, in een kwaad daglicht. Ik vind de stellingname van collega Batstra te ongenuanceerd en polariserend. Met haar kanttekeningen t.a.v. de medicamenteuze behandeling van ADHD gaat ze als psycholoog in ieder geval haar boekje te buiten, omdat het buiten haar deskundigheidsgebied valt.
Hoog tijd dus voor meer nuance in het ADHD debat! In het mei-nummer van het vaktijdschrift De Psychiater vond ik het onderstaande artikel van prof. Vermeiren en Arga Paternotte, dat de benodigde nuancering aanbrengt:
Tenslotte verwijs ik naar de eerdere bijdrage in Psychotopics waarin het artikel aan bod kwam dat in 2011 verscheen in het tijdschrift Medisch Contact om stelling te nemen tegen het idee dat ADHD een modediagnose zou zijn en de bijgaande video.
Abonneren op:
Posts (Atom)